{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:39:07Z","timestamp":1792535947339,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"43","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,11]]},"DOI":"10.1038\/s41388-026-03978-4","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:03:41Z","timestamp":1789560221000},"page":"4689-4702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["JNK acts as a molecular brake of the CDC73 positive feedback loop to modulate osteosarcoma malignant progression via UBR5"],"prefix":"10.1038","volume":"45","author":[{"given":"Dingji","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huigen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IoHong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengchao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengnong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8902-1243","authenticated-orcid":false,"given":"Baoshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"3978_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1006400","volume":"10","author":"HC Zheng","year":"2022","unstructured":"Zheng HC, Xue H, Zhang CY. The roles of the tumor suppressor parafibromin in cancer. Front Cell Dev Biol. 2022;10:1006400.","journal-title":"Front Cell Dev Biol"},{"key":"3978_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/crie\/4340464","volume":"2025","author":"C Elena","year":"2025","unstructured":"Elena C, Andrea C, Di Giovanni F, Alessandra L, Mirella F, Antonella M. Hyperparathyroidism-Jaw Tumor Syndrome Associated to a CDC73 Gene Pathogenic VARIANT and a Nonossifying Desmoplastic Fibroma of the Mandible. Case Rep Endocrinol. 2025;2025:4340464.","journal-title":"Case Rep Endocrinol"},{"key":"3978_CR3","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1093\/nar\/gkz124","volume":"47","author":"L Haronikova","year":"2019","unstructured":"Haronikova L, Olivares-Illana V, Wang L, Karakostis K, Chen S, F\u00e5hraeus R. The p53 mRNA: an integral part of the cellular stress response. Nucleic Acids Res. 2019;47:3257\u201371.","journal-title":"Nucleic Acids Res"},{"key":"3978_CR4","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood.2023020144","volume":"142","author":"AF Melnick","year":"2023","unstructured":"Melnick AF, Mullin C, Lin K, McCarter AC, Liang S, Liu YE, et al. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress. Blood. 2023;142:2159\u201374.","journal-title":"Blood"},{"key":"3978_CR5","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1128\/MCB.25.12.5052-5060.2005","volume":"25","author":"A Yart","year":"2005","unstructured":"Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D, et al. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol. 2005;25:5052\u201360.","journal-title":"Mol Cell Biol"},{"key":"3978_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21520-w","volume":"12","author":"D van den Heuvel","year":"2021","unstructured":"van den Heuvel D, Spruijt CG, Gonz\u00e1lez-Prieto R, Kragten A, Paulsen MT, Zhou D, et al. A CSB-PAF1C axis restores processive transcription elongation after DNA damage repair. Nat Commun. 2021;12:1342.","journal-title":"Nat Commun"},{"key":"3978_CR7","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112756","volume":"42","author":"C Li","year":"2023","unstructured":"Li C, Guo Y, Wang L, Yan S. The SMC5\/6 complex recruits the PAF1 complex to facilitate DNA double-strand break repair in Arabidopsis. Embo J. 2023;42:e112756.","journal-title":"Embo J"},{"key":"3978_CR8","first-page":"1565","volume":"17","author":"FQ Yu","year":"2019","unstructured":"Yu FQ, Wang Z, Wang XW, Wang SL, Li XD, Huang QS, et al. MicroRNA-885-5p promotes osteosarcoma proliferation and migration by downregulation of cell division cycle protein 73 homolog expression. Oncol Lett. 2019;17:1565\u201372.","journal-title":"Oncol Lett"},{"key":"3978_CR9","doi-asserted-by":"crossref","unstructured":"Kim SY, Lee JY, Cho YJ, Jo KH, Kim ES, Han JH, et al. USP37 Deubiquitinates CDC73 in HPT-JT Syndrome. Int J Mol Sci. 2022;23,6364.","DOI":"10.3390\/ijms23126364"},{"key":"3978_CR10","doi-asserted-by":"publisher","first-page":"17420","DOI":"10.1073\/pnas.0710725105","volume":"105","author":"L Lin","year":"2008","unstructured":"Lin L, Zhang JH, Panicker LM, Simonds WF. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene. Proc Natl Acad Sci USA 2008;105:17420\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3978_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45760-8","volume":"15","author":"A Gaballa","year":"2024","unstructured":"Gaballa A, Gebhardt-Wolf A, Krenz B, Mattavelli G, John M, Cossa G, et al. PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma. Nat Commun. 2024;15:1446.","journal-title":"Nat Commun"},{"key":"3978_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molcel.2011.05.014","volume":"43","author":"A Takahashi","year":"2011","unstructured":"Takahashi A, Tsutsumi R, Kikuchi I, Obuse C, Saito Y, Seidi A, et al. SHP2 tyrosine phosphatase converts parafibromin\/Cdc73 from a tumor suppressor to an oncogenic driver. Mol Cell. 2011;43:45\u201356.","journal-title":"Mol Cell"},{"key":"3978_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1073\/pnas.0812023106","volume":"106","author":"O Rozenblatt-Rosen","year":"2009","unstructured":"Rozenblatt-Rosen O, Nagaike T, Francis JM, Kaneko S, Glatt KA, Hughes CM, et al. The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3\u2019 mRNA processing factors. Proc Natl Acad Sci USA 2009;106:755\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3978_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148258","volume":"906","author":"B Hu","year":"2024","unstructured":"Hu B, Chen S. The role of UBR5 in tumor proliferation and oncotherapy. Gene. 2024;906:148258.","journal-title":"Gene"},{"key":"3978_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101062","volume":"59","author":"X Wang","year":"2025","unstructured":"Wang X, Wang X, Gu J, Wei Y, Wang Y. circUBR5 promotes ribosome biogenesis and induces docetaxel resistance in triple-negative breast cancer cell lines via the miR-340-5p\/CMTM6\/c-MYC axis. Neoplasia. 2025;59:101062.","journal-title":"Neoplasia"},{"key":"3978_CR16","doi-asserted-by":"crossref","unstructured":"Lin H, Zhang L, Liu B, Cui G. UBR5 Significantly correlates with osteosarcomas prognosis and immune exhaustion characteristic in the tumor microenvironment. Curr Cancer Drug Targets. 2023;24,69-79.","DOI":"10.2174\/1568009623666230529140739"},{"key":"3978_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/ijc.34769","volume":"154","author":"Z Yu","year":"2024","unstructured":"Yu Z, Dong X, Song M, Xu A, He Q, Li H, et al. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis. Int J Cancer. 2024;154:723\u201337.","journal-title":"Int J Cancer"},{"key":"3978_CR18","first-page":"405","volume":"120","author":"K Zarghooni","year":"2023","unstructured":"Zarghooni K, Bratke G, Landgraf P, Simon T, Maintz D, Eysel P. The Diagnosis and Treatment of Osteosarcoma and Ewing\u2019s Sarcoma in Children and Adolescents. Dtsch Arztebl Int. 2023;120:405\u201312.","journal-title":"Dtsch Arztebl Int"},{"key":"3978_CR19","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/1097-0142(197906)43:6<2163::AID-CNCR2820430602>3.0.CO;2-S","volume":"43","author":"G Rosen","year":"1979","unstructured":"Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer. 1979;43:2163\u201377.","journal-title":"Cancer"},{"key":"3978_CR20","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3892\/ol.2014.1935","volume":"7","author":"H He","year":"2014","unstructured":"He H, Ni J, Huang J. Molecular mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett. 2014;7:1352\u201362.","journal-title":"Oncol Lett"},{"key":"3978_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbrc.2020.12.109","volume":"554","author":"GT Fan","year":"2021","unstructured":"Fan GT, Ling ZH, He ZW, Wu SJ, Zhou GX. Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma. Biochem Biophys Res Commun. 2021;554:214\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"3978_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1158\/1078-0432.CCR-24-4275","volume":"32","author":"Q Yu","year":"2026","unstructured":"Yu Q, Geng M, Lu Y, Zhang X, Tong S, Wang Y, et al. Spermidine Secreted by Apoptotic Cells Enhances Chemotherapy Resistance by Modulating \u03b2-Catenin Activity in Osteosarcoma. Clin Cancer Res. 2026;32:390\u2013404.","journal-title":"Clin Cancer Res"},{"key":"3978_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1158\/2159-8290.CD-17-1152","volume":"9","author":"LC Sayles","year":"2019","unstructured":"Sayles LC, Breese MR, Koehne AL, Leung SG, Lee AG, Liu HY, et al. Genome-Informed Targeted Therapy for Osteosarcoma. Cancer Discov. 2019;9:46\u201363.","journal-title":"Cancer Discov"},{"key":"3978_CR24","doi-asserted-by":"crossref","unstructured":"Choo YS, Zhang Z. Detection of protein ubiquitination. J Vis Exp. 2009;1293.","DOI":"10.3791\/1293-v"},{"key":"3978_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04914-6","volume":"13","author":"G Xiang","year":"2022","unstructured":"Xiang G, Wang S, Chen L, Song M, Song X, Wang H, et al. UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer. Cell Death Dis. 2022;13:451.","journal-title":"Cell Death Dis"},{"key":"3978_CR26","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","volume":"25","author":"O Rozenblatt-Rosen","year":"2005","unstructured":"Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, et al. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol. 2005;25:612\u201320.","journal-title":"Mol Cell Biol"},{"key":"3978_CR27","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1158\/0008-5472.CAN-16-2409","volume":"77","author":"L Liao","year":"2017","unstructured":"Liao L, Song M, Li X, Tang L, Zhang T, Zhang L, et al. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer. Cancer Res. 2017;77:2090\u2013101.","journal-title":"Cancer Res"},{"key":"3978_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20140-0","volume":"11","author":"M Song","year":"2020","unstructured":"Song M, Yeku OO, Rafiq S, Purdon T, Dong X, Zhu L, et al. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun. 2020;11:6298.","journal-title":"Nat Commun"},{"key":"3978_CR29","doi-asserted-by":"crossref","unstructured":"Odhiambo DA, Fan S, Hirbe AC UBR5 in tumor biology: exploring mechanisms of immune regulation and possible therapeutic implications in MPNST. Cancers. 2025;14,283.","DOI":"10.20944\/preprints202411.1939.v1"},{"key":"3978_CR30","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41401-024-01290-z","volume":"45","author":"C-Y Duan","year":"2024","unstructured":"Duan C-Y, Li Y, Zhi H-Y, Tian Y, Huang Z-Y, Chen S-P, et al. E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1. Acta Pharmacologica Sinica. 2024;45:1793\u2013808.","journal-title":"Acta Pharmacologica Sinica"},{"key":"3978_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41589-023-01414-2","volume":"20","author":"LA Hehl","year":"2024","unstructured":"Hehl LA, Horn-Ghetko D, Prabu JR, Vollrath R, Vu DT, P\u00e9rez Berrocal DA, et al. Structural snapshots along K48-linked ubiquitin chain formation by the HECT E3 UBR5. Nat Chem Biol. 2024;20:190\u2013200.","journal-title":"Nat Chem Biol"},{"key":"3978_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156301","volume":"278","author":"H Cui","year":"2026","unstructured":"Cui H, Fan X. Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer. Pathol Res Pract. 2026;278:156301.","journal-title":"Pathol Res Pract"},{"key":"3978_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40262-018-0702-1","volume":"58","author":"N Gupta","year":"2019","unstructured":"Gupta N, Hanley MJ, Xia C, Labotka R, Harvey RD, Venkatakrishnan K. Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor. Clin Pharmacokinet. 2019;58:431\u201349.","journal-title":"Clin Pharmacokinet"},{"key":"3978_CR34","doi-asserted-by":"publisher","first-page":"18090","DOI":"10.1074\/jbc.M011396200","volume":"276","author":"H Habelhah","year":"2001","unstructured":"Habelhah H, Shah K, Huang L, Burlingame AL, Shokat KM, Ronai Z. Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue. J Biol Chem. 2001;276:18090\u20135.","journal-title":"J Biol Chem"},{"key":"3978_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbapap.2007.09.013","volume":"1784","author":"MA Bogoyevitch","year":"2008","unstructured":"Bogoyevitch MA, Arthur PG. Inhibitors of c-Jun N-terminal kinases: JuNK no more? Biochim Biophys Acta. 2008;1784:76\u201393.","journal-title":"Biochim Biophys Acta"},{"key":"3978_CR36","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1158\/1541-7786.MCR-15-0383","volume":"13","author":"RF Shearer","year":"2015","unstructured":"Shearer RF, Iconomou M, Watts CK, Saunders DN. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer. Mol Cancer Res. 2015;13:1523\u201332.","journal-title":"Mol Cancer Res"},{"key":"3978_CR37","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1097\/JS9.0000000000001541","volume":"110","author":"Y Wang","year":"2024","unstructured":"Wang Y, Niu K, Shi Y, Zhou F, Li X, Li Y, et al. A review: targeting UBR5 domains to mediate emerging roles and mechanisms - chance or necessity? Int J Surg. 2024;110:4947\u201364.","journal-title":"Int J Surg"},{"key":"3978_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1099414","volume":"306","author":"M Gao","year":"2004","unstructured":"Gao M, Labuda T, Xia Y, Gallagher E, Fang D, Liu YC, et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science. 2004;306:271\u20135.","journal-title":"Science"},{"key":"3978_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jprot.2011.08.023","volume":"75","author":"JR Bethard","year":"2011","unstructured":"Bethard JR, Zheng H, Roberts L, Eblen ST. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5\/EDD. J Proteomics. 2011;75:603\u20139.","journal-title":"J Proteomics"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03978-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:02:28Z","timestamp":1792533748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03978-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":39,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2026,11,11]]}},"alternative-id":["3978"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03978-4","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We declare that there are no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The human osteosarcoma tissue microarray (Lot# KB2025-\u4f26\u7406\u610f\u89c1-48-01) (the clinical trial registration number:TBS-01) used in this study was purchased from Xi\u2019an Taibosi Biological Company (Xi\u2019an, China). According to the supplier, all human tissue samples included in the microarray were collected with appropriate ethical approval, and informed consent was obtained from all donors. All experimental methods described in this study were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}